Laz, I don't think they could afford to lose FRO now, simply because to do so at this time would place their entire credibility at risk (what is their plan really all about?), from a perceptual standpoint. It's already difficult enough to assign any level of coherency to them now, to what was once (about a month ago) viewed as a relatively straightforward and pure play.
I'm not suggesting that they are in deep trouble or in a tail spin, by any means, at least not yet. There's plenty of room for optimizing the situation and coming out for the better. But there's bound to be some breakage until the fog lifts.
The strength of their image is being tested, and is starting to wear thin at this time. They've gone ahead and done too many seemingly incongruous things, all at once, IMO, which makes it difficult to focus on their game plan with any certainty right now, as relates to where they are headed and how they plan to get there.
My youngest son is a broker who deals primarily in bio-meds, genetics and pharms. Last night, he asked me about this company, asking "What do they do?"
Anyone try answering that one lately?
I replied with another question, and asked him, "When?"
I'm open to suggestions and comments, as always.
Regards, Frank Coluccio |
